A clinical trial to reduce the recurrence rate following interferon (IFN) therapy in patients with chronic hepatitis B; Effects of individualization of treatment duration according to response of serum HBV-DNA

被引:0
|
作者
Chung, YH [1 ]
Lee, GC [1 ]
Song, BC [1 ]
Kim, HG [1 ]
Lee, YS [1 ]
Suh, DJ [1 ]
机构
[1] UNIV ULSAN, COLL MED, ASAN MED CTR, DEPT INTERNAL MED, SEOUL, SOUTH KOREA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A1245 / A1245
页数:1
相关论文
共 50 条
  • [21] Preliminary results of Thymosin-a1 versus interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B
    Zhuang, L
    You, J
    Tang, BZ
    Ding, SY
    Yan, KH
    Peng, D
    Zhang, YM
    Zhang, L
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (03) : 407 - 410
  • [22] Suppression of serum HBV DNA and reduction in serum amino transferase levels following 12 weeks of Adefovir dipivoxil therapy in chronic hepatitis B patients with HBeAg(-)/anti-HBE(+)/HBV DNA(+) HBV infection.
    Heathcote, EJ
    Thai, Q
    Margulies, M
    Fry, J
    Gibbs, CS
    McNaughton, D
    Westland, CE
    Xiong, X
    Yang, H
    Brosgart, C
    HEPATOLOGY, 2000, 32 (04) : 586A - 586A
  • [23] Prediction of the Response to Pegylated Interferon α-2a in Patients with HBeAg Positive Chronic Hepatitis B through Decline of Serum HBV DNA and Hepatitis B Virus Surface Antigen at Week 4
    Jian-ming Zheng
    Ming-quan Chen
    Meng-qi Zhu
    Ning Li
    Qian Li
    Xin-yu Wang
    Chong Huang
    Guang-feng Shi
    InfectionInternational(ElectronicEdition), 2012, 1 (04) : 183 - 190
  • [24] Comparison of two HBV-DNA hybridization assays of sera from patients completing a clinical trial of thymosin alpha(1) (T alpha(1)) in chronic hepatitis B (CHB).
    Naylor, PH
    Nathani, M
    Peleman, R
    Ehrinpreis, MN
    Mutchnick, MG
    GASTROENTEROLOGY, 1996, 110 (04) : A1276 - A1276
  • [25] On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy
    Huang, Yi-Wen
    Takahashi, Shoichi
    Tsuge, Masataka
    Chen, Chi-Ling
    Wang, Ting-Chuan
    Abe, Hiromi
    Hu, Jui-Ting
    Chen, Ding-Shinn
    Yang, Sien-Sing
    Chayama, Kazuaki
    Kao, Jia-Horng
    ANTIVIRAL THERAPY, 2015, 20 (04) : 369 - 375
  • [26] Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels
    Shin, J. W.
    Jung, S. W.
    Park, B. R.
    Kim, C. J.
    Eum, J. B.
    Kim, B. G.
    Jeong, I. D.
    Bang, S. -J.
    Lee, S. -H.
    Kim, S. R.
    Park, N. H.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (10) : 724 - 731
  • [27] IMPACT OF PRE-TREATMENT SERUM HBV DNA LEVELS ON THE RATE OF ALT NORMALIZATION DURING ANTIVIRAL THERAPY WITH ENTECAVIR OR TENOFOVIR DISOPROXIL FUMARATE FOR CHRONIC HEPATITIS B
    Choi, Jonggi
    Choi, Won-Mook
    Lim, Young-Suk
    HEPATOLOGY, 2020, 72 : 486A - 486A
  • [28] LONG-TERM RESPONSE TO HIGHER DOSES OF INTERFERON (IFN) ALFA-2B TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS-C - A RANDOMIZED MULTICENTER TRIAL
    LINDSAY, KL
    DAVIS, GL
    SCHIFF, E
    BODENHEIMER, H
    BALART, L
    DIENSTAG, J
    PERRILLO, R
    TAMBURRO, C
    SILVA, M
    GOFF, C
    EVERSON, G
    SANGHVI, B
    ALBRECHT, J
    HEPATOLOGY, 1993, 18 (04) : A106 - A106
  • [29] Alteration of intercellular adhesion molecule-1 (ICAM-1) expression in the liver and serum level of HBV DNA in chronic hepatitis B patients after interferon treatment
    Zheng Rui-dan
    Su Ya-yong
    Lu Yan-hui
    Meng Jia-rong
    Zhang Min-feng
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2011, 5 (10): : 1211 - 1214
  • [30] IMPROVED HBeAg SEROCONVERSION BY SEQUENTIAL TELBIVUDINE THERAPY FOLLOWING PARTIAL RESPONSE TO PEGYLATED INTERFERON TREATMENT IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS
    Zheng, Q.
    Zhu, Y. Y.
    Chen, J.
    Liu, R. Y.
    Dong, J.
    Zeng, W. D.
    Jiang, J. J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S432 - S432